| Literature DB >> 35019245 |
Sarah Noetzlin1, Gautier Breville1, Jörg D Seebach1, Giacomo Gastaldi1.
Abstract
Glucocorticoids are the mainstay treatment of a variety of inflammatory and autoimmune disorders. Unfortunately, metabolic side effects, drug interactions and adverse reactions commonly lead to glucocorticoid-related side effects, thereby compromising their intended anti-inflammatory and immunosuppressive effects. The goal of this review is to help clinicians to monitor the broad spectrum of side effects of short-term systemic glucocorticoid administration, defined as glucocorticoid treatment shorter than 30 days. We review the various systems affected, with a focus on metabolic conditions and hyperglycaemia management.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35019245 DOI: 10.4414/smw.2022.w30088
Source DB: PubMed Journal: Swiss Med Wkly ISSN: 0036-7672 Impact factor: 2.193